REMIBRUTINIB Pharmacologic Class Indexing
- Class set ID
- 6a5d3e8a-b762-461b-9db5-4e481ba9699e
- Version
- 1
- Effective date
- 20251202
- Type
- Indexing - Pharmacologic Class
Mapped DailyMed Labels#
| Label | Manufacturer | Effective | SPL version |
|---|---|---|---|
| These highlights do not include all the information needed to use RHAPSIDO safely and effectively. See full prescribing information for RHAPSIDO. RHAPSIDO ® (remibrutinib) tablets, for oral use Initial U.S. Approval: 2025 | Novartis Pharmaceuticals Corporation | 20260323 | 2 |